DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
Clinical trial NCT05378360 · COMPLETED
Trial details
- NCT number
- NCT05378360
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2023-12-05
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.